Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the compliance of Certificate under Regulation 74(5) of SEBI DP Regulations
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd has submitted a routine compliance certificate to BSE under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. The certificate was issued by their Registrar and Share Transfer Agent, Adroit Corporate Services Pvt. Ltd., confirming that all securities received from depository participants for dematerialisation during the quarter were duly processed. The RTA further confirmed that physical share certificates received for demat were mutilated and cancelled, with the depository's name substituted as registered owner in the company's register of members within the stipulated 15-day timeline. This is a standard quarterly compliance submission required from every listed company and carries no business or financial information.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or stock price. It merely confirms that the company's share dematerialisation process was handled correctly during the January-March 2025 quarter.